piperidines and Skin-Diseases--Vascular

piperidines has been researched along with Skin-Diseases--Vascular* in 3 studies

Other Studies

3 other study(ies) available for piperidines and Skin-Diseases--Vascular

ArticleYear
Tofacitinib for the treatment of refractory or glucocorticoid-dependent cutaneous leukocytoclastic vasculitis.
    Dermatologic therapy, 2022, Volume: 35, Issue:11

    Topics: Glucocorticoids; Humans; Piperidines; Skin Diseases, Vascular; Vasculitis, Leukocytoclastic, Cutaneous

2022
Atypical Painful Purpuric Cutaneous Nodules With Ibrutinib.
    The American Journal of dermatopathology, 2020, Volume: 42, Issue:12

    Topics: Adenine; Aged; Antineoplastic Agents; Drug Eruptions; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Skin Diseases, Vascular; Vasculitis

2020
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Humans; Livedo Reticularis; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Diseases, Vascular; Skin Ulcer; Vascular Diseases

2020